These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 6763556)

  • 21. Prolonged survival of allogeneic mouse skin grafts following preservation.
    Cohen I; Yemini M; Wexler MR; Brautbar H
    Isr J Med Sci; 1980; 16(9-10):628-30. PubMed ID: 7000732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of antipassenger lymphocyte globulin on functional graft survival of discordant xenoislet grafts from a large animal donor.
    Troppmann C; Papalois BE; Gruessner AC; Moon C; Matas AJ; Nakhleh RE; Gruessner RW
    Transplant Proc; 1996 Apr; 28(2):842-4. PubMed ID: 8623429
    [No Abstract]   [Full Text] [Related]  

  • 23. Mouse skin graft prolongation with donor strain bone marrow and antilymphocyte serum. Effect of donor age.
    De Fazio SR; Hartner WC; Monaco AP; Gozzo JJ
    Transplantation; 1985 Nov; 40(5):563-4. PubMed ID: 3904092
    [No Abstract]   [Full Text] [Related]  

  • 24. Bromocriptine prevents the immunosuppression induced in mice by anti-lymphocytic antiserum.
    Rosso di San Secondo VE; Fitch C; Aniasi A; Close FT; Sirchia G; Freeman ME
    Transplant Proc; 1996 Dec; 28(6):3193-5. PubMed ID: 8962238
    [No Abstract]   [Full Text] [Related]  

  • 25. Specificity requirement of donor bone marrow cells that prolong allograft survival: implications for a veto cell mechanism of action.
    De Fazio SR; Markees TG; Hartner WC; Gozzo JJ
    Transplant Proc; 1995 Feb; 27(1):171-3. PubMed ID: 7878960
    [No Abstract]   [Full Text] [Related]  

  • 26. Fractionated bone marrow: use of a lymphocyte containing fraction for skin allograft prolongation in antilymphocyte serum (ALS) treated mice.
    Gozzo JJ; Litvin DA; Bhatnagar YM; Monaco AP
    Transplant Proc; 1981 Mar; 13(1 Pt 1):592-5. PubMed ID: 7022895
    [No Abstract]   [Full Text] [Related]  

  • 27. Abrogation of recurrent autoimmunity in the NOD mouse: A critical role for host interleukin 4.
    Shi Q; Wang D; Hadley GA; Farber DL; Bartlett ST
    Surgery; 2006 Aug; 140(2):281-8. PubMed ID: 16904981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adaptation of skin grafts in the mouse to antibody-mediated rejection.
    Gerlag PG; Capel PJ; Hagemann JF; Koene RA
    J Immunol; 1980 Aug; 125(2):583-6. PubMed ID: 6993559
    [No Abstract]   [Full Text] [Related]  

  • 29. Genetic control of allograft tolerance: importance of H-2 subregions.
    Click RE; Cahill G; Condie RM; Azar MM; Najarian JS
    Transplant Proc; 1981 Mar; 13(1 Pt 1):582-5. PubMed ID: 7022894
    [No Abstract]   [Full Text] [Related]  

  • 30. Suppression of immune responses by progesterone.
    Kincl FA; Ciaccio LA
    Endocrinol Exp; 1980 Mar; 14(1):27-33. PubMed ID: 6995101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Grafts of human skin containing nevi or superficial nevocarcinoma onto athymic nu/nu mice: macroscopic and microscopic studies].
    Duprez A
    C R Seances Acad Sci D; 1980 Feb; 290(6):461-4. PubMed ID: 6767555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term survival of xenogeneic skin grafts in widely disparate combinations.
    Bouwman E; Wolvekamp MC; Scheringa M; de Bruin RW; Bonthuis F; Jeekel J; Marquet RL
    Transplant Proc; 1993 Feb; 25(1 Pt 1):383-4. PubMed ID: 8438345
    [No Abstract]   [Full Text] [Related]  

  • 33. Role of HLA-DP antigen in xenogeneic iso-skin grafts using transgenic mice.
    Tsuji K; Inoko H; Hagihara M; Shimura T; Sato T; Ando A
    Transplant Proc; 1993 Feb; 25(1 Pt 1):136-7. PubMed ID: 8438252
    [No Abstract]   [Full Text] [Related]  

  • 34. Skin allograft survival following intrathymic injection of donor bone marrow.
    Cober SR; Randolph MA; Lee WP
    J Surg Res; 1999 Aug; 85(2):204-8. PubMed ID: 10423320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of donor bone marrow cell-derived chimerism in transplantation tolerance using transgenic mice.
    Smith JP; Kasten-Jolly J; Field LJ; Thomas JM
    Transplantation; 1994 Aug; 58(3):324-9. PubMed ID: 8053056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of immunosuppression with anti-T-cell monoclonal antibodies on the survival of organ-cultured fetal pig pancreas xenografts in nonobese diabetic mice.
    Mandel TE; Koulmanda M
    Transplant Proc; 1993 Oct; 25(5):2926-7. PubMed ID: 8212286
    [No Abstract]   [Full Text] [Related]  

  • 37. Prolongation of concordant islet xenografts with leflunomide.
    Lakey JR; Yatscoff RW; Koshal A; Rajotte RV
    Transplant Proc; 1996 Apr; 28(2):816. PubMed ID: 8623414
    [No Abstract]   [Full Text] [Related]  

  • 38. Rabbit antithymocyte globulin related decrease in platelet count reduced risk of pediatric renal transplant graft thrombosis.
    Kamel MH; Mohan P; Conlon PJ; Little DM; O'Kelly P; Hickey DP
    Pediatr Transplant; 2006 Nov; 10(7):816-21. PubMed ID: 17032428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mouse skin allograft model for study of pregraft blood transfusion.
    Maki T; Okazaki H; Wood ML; Monaco AP
    Transplant Proc; 1982 Jun; 14(2):394-6. PubMed ID: 7051485
    [No Abstract]   [Full Text] [Related]  

  • 40. Prolonged survival of human skin xenografts on antithymocyte serum-treated mice: failure to produce verrucae by inoculation with extracts of human warts.
    Pass F; Nimura M; Kreider JW
    J Invest Dermatol; 1973 Dec; 61(6):371-4. PubMed ID: 4585822
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.